These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 24276)
21. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage I-II preparations in the therapy of internal diseases]. Grebnev AL; Miagkova LP; Kkhorshed AM Klin Med (Mosk); 1991 Mar; 69(3):23-7. PubMed ID: 1676772 [No Abstract] [Full Text] [Related]
22. [The interaction potential of H2 receptor antagonists. A short current review]. Klotz U; Kroemer HK Fortschr Med; 1991 Sep; 109(28):574-6. PubMed ID: 1684557 [No Abstract] [Full Text] [Related]
23. [What is the role of H2 receptor blockers today in ulcer therapy?]. Creutzfeldt W Internist (Berl); 1996 Sep; 37(9):937-8. PubMed ID: 8964690 [No Abstract] [Full Text] [Related]
24. [The use of histamine H2 receptor blockaders in gastroenterology]. Waldum HL; Petersen H Tidsskr Nor Laegeforen; 1983 Apr; 103(12):980-3. PubMed ID: 6136102 [No Abstract] [Full Text] [Related]
26. [Ulcer surgery before and after administration of H2 blockader treatment]. Christensen A; Bousfield R Ugeskr Laeger; 1987 Oct; 149(43):2895-7. PubMed ID: 2893482 [No Abstract] [Full Text] [Related]
27. Famotidine: clinical applications of a new H2-receptor antagonist. May 16, 1986, Carmel, California. Am J Med; 1986 Oct; 81(4B):1-64. PubMed ID: 2877568 [No Abstract] [Full Text] [Related]
28. [Peptic ulcer: how to treat it long term]. Zaterka S; Bettarello A Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(1):1-3. PubMed ID: 2892245 [No Abstract] [Full Text] [Related]
29. Eradication treatment for Helicobacter pylori in general practice. Fraser AG; Moore L; Berry S; Arroll B N Z Med J; 1996 Nov; 109(1033):422-4. PubMed ID: 8941293 [TBL] [Abstract][Full Text] [Related]
30. [Clinical, secretory, radiological and endoscopic evolution of patients with gastroduodenal ulcer treated with Ulcosilvanil, as compared with those treated with histamine H2 receptor antagonists]. Contraşiu P; Calinici V Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(4):359-63. PubMed ID: 6113650 [No Abstract] [Full Text] [Related]
32. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases]. Miagkova LP; Grebenev AL; Kkhorshed AM Klin Med (Mosk); 1991 Mar; 69(3):27-34. PubMed ID: 1676773 [No Abstract] [Full Text] [Related]
33. Histamine H2-receptor antagonists and peptic ulcer disease. Thompson MH South Med J; 1978 Jul; 71(7):753. PubMed ID: 26979 [No Abstract] [Full Text] [Related]
34. [Treatment of peptic ulcer]. Stray N Tidsskr Nor Laegeforen; 1980 May; 100(13):908-10. PubMed ID: 6104371 [No Abstract] [Full Text] [Related]
35. Treatment of peptic ulcer disease: is Helicobacter pylori a consideration? Pajares JM; Carballo F; Blanco M Hepatogastroenterology; 1992 Feb; 39 Suppl 1():40-4. PubMed ID: 1349551 [No Abstract] [Full Text] [Related]
36. Clinical relevance of tolerance to peptic ulcer healing and relapse. Misiewicz JJ Aliment Pharmacol Ther; 1990; 4 Suppl 1():85-96. PubMed ID: 1983350 [No Abstract] [Full Text] [Related]
37. Modern management of peptic ulcer. Colley S Practitioner; 1992 Oct; 236(1519):956-61. PubMed ID: 1363332 [No Abstract] [Full Text] [Related]
38. [Surgical therapy of the peptic ulcer in a hospital specializing in gastroenterology. Effects of therapy with h2 antagonists]. Lorusso D; Pezzolla F; Lantone G; Misciagna G; Guerra V Minerva Chir; 1997 Nov; 52(11):1293-7. PubMed ID: 9489325 [TBL] [Abstract][Full Text] [Related]